1. Home
  2. VYGR vs KOD Comparison

VYGR vs KOD Comparison

Compare VYGR & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • KOD
  • Stock Information
  • Founded
  • VYGR 2013
  • KOD 2009
  • Country
  • VYGR United States
  • KOD United States
  • Employees
  • VYGR N/A
  • KOD N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VYGR Health Care
  • KOD Health Care
  • Exchange
  • VYGR Nasdaq
  • KOD Nasdaq
  • Market Cap
  • VYGR 206.9M
  • KOD 198.4M
  • IPO Year
  • VYGR 2015
  • KOD 2018
  • Fundamental
  • Price
  • VYGR $4.24
  • KOD $10.52
  • Analyst Decision
  • VYGR Strong Buy
  • KOD Hold
  • Analyst Count
  • VYGR 7
  • KOD 4
  • Target Price
  • VYGR $14.50
  • KOD $11.75
  • AVG Volume (30 Days)
  • VYGR 678.8K
  • KOD 673.8K
  • Earning Date
  • VYGR 08-06-2025
  • KOD 08-13-2025
  • Dividend Yield
  • VYGR N/A
  • KOD N/A
  • EPS Growth
  • VYGR N/A
  • KOD N/A
  • EPS
  • VYGR N/A
  • KOD N/A
  • Revenue
  • VYGR $42,580,000.00
  • KOD N/A
  • Revenue This Year
  • VYGR N/A
  • KOD N/A
  • Revenue Next Year
  • VYGR $107.07
  • KOD N/A
  • P/E Ratio
  • VYGR N/A
  • KOD N/A
  • Revenue Growth
  • VYGR N/A
  • KOD N/A
  • 52 Week Low
  • VYGR $2.65
  • KOD $1.92
  • 52 Week High
  • VYGR $8.28
  • KOD $11.60
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 70.98
  • KOD 64.28
  • Support Level
  • VYGR $3.32
  • KOD $8.29
  • Resistance Level
  • VYGR $3.49
  • KOD $9.23
  • Average True Range (ATR)
  • VYGR 0.23
  • KOD 0.98
  • MACD
  • VYGR 0.06
  • KOD -0.16
  • Stochastic Oscillator
  • VYGR 94.03
  • KOD 74.33

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Share on Social Networks: